Please wait while the formulary information is being retrieved.
Drug overview for SPIKEVAX 2023-2024(12Y UP)(PF) (covid vacc 2023-24 (12 yrs and up) xbb.1.5 (andusomeran)/pf):
Generic name: COVID vacc 2023-24 (12 yrs and up) XBB.1.5 (andusomeran)/PF
Drug class:
Therapeutic class:
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
Generic name: COVID vacc 2023-24 (12 yrs and up) XBB.1.5 (andusomeran)/PF
Drug class:
Therapeutic class:
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
DRUG IMAGES
- No Image Available
The following indications for SPIKEVAX 2023-2024(12Y UP)(PF) (covid vacc 2023-24 (12 yrs and up) xbb.1.5 (andusomeran)/pf) have been approved by the FDA:
Indications:
None.
Professional Synonyms:
None.
Indications:
None.
Professional Synonyms:
None.